Short answer
Elevance Health (ELV) filed an 8-K current report with the SEC on November 10, 2026 reporting Item 7.01 (Regulation FD Disclosure). 2026 shareholders’ earnings guidance reaffirmed at least $22.00 per diluted share.
Elevance Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- 2026 shareholders’ earnings guidance reaffirmed at least $22.00 per diluted share
- Approximately $7.00 per diluted share of net unfavorable items included in reported guidance
- Adjusted shareholders’ earnings guidance maintained at least $29.00 per diluted share
- Benefit expense ratio guidance reaffirmed at 90.2%, plus or minus 50 basis points
- Investor meetings this week provide a near-term confirmation of management’s outlook ahead of future results
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Elevance Health 8-K filings
Get the next ELV 8-K as it lands
Follow ELV for push alerts, or ask the research agent what this filing means.